GPP

Great Point Partners Portfolio holdings

AUM $154M
This Quarter Return
-11.03%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$945M
AUM Growth
+$945M
Cap. Flow
+$265M
Cap. Flow %
27.99%
Top 10 Hldgs %
67.34%
Holding
41
New
14
Increased
11
Reduced
4
Closed
5
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TPTX
26
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$8.36M 0.77%
+222,222
New +$8.36M
VYNE icon
27
VYNE Therapeutics
VYNE
$8.09M
$7.4M 0.68%
1,652,013
-81,869
-5% -$367K
ABEO icon
28
Abeona Therapeutics
ABEO
$356M
$7.31M 0.67%
+3,235,601
New +$7.31M
ATRA icon
29
Atara Biotherapeutics
ATRA
$88.7M
$7.06M 0.65%
+500,000
New +$7.06M
EXEL icon
30
Exelixis
EXEL
$9.95B
$5.48M 0.5%
+309,700
New +$5.48M
KA
31
DELISTED
Kineta, Inc. Common Stock
KA
$2.96M 0.27%
3,500,000
MYOV
32
DELISTED
Myovant Sciences Ltd.
MYOV
$1.69M 0.16%
+325,000
New +$1.69M
OPK icon
33
Opko Health
OPK
$1.1B
$193K 0.02%
+92,140
New +$193K
STRM
34
DELISTED
Streamline Health Solutions
STRM
$141K 0.01%
130,137
AXSM icon
35
Axsome Therapeutics
AXSM
$6.09B
0
LRMR icon
36
Larimar Therapeutics
LRMR
$337M
-2,211,194
Closed -$2.63M
RVLP
37
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
-926,933
Closed -$3.52M
FPRX
38
DELISTED
Five Prime Therapeutics, Inc.
FPRX
-547,712
Closed -$3.3M
FOMX
39
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
-2,110,071
Closed -$5.02M
MDCO
40
DELISTED
Medicines Co
MDCO
0
BHVN
41
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-350,000
Closed -$15.3M